Mead Johnson Nutrition
81
1
4
63
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.8%
12 terminated/withdrawn out of 81 trials
84.0%
-2.5% vs industry average
2%
2 trials in Phase 3/4
8%
5 of 63 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (81)
Thai Baby Study Phase 1
Role: lead
Reason for Prescribing Rice Infant Formula
Role: lead
Effect of Vitamin D in Diets of Preterm Infants
Role: collaborator
Enfamil NeuroPro Study
Role: collaborator
Early Human Milk Fortification After Early, Exclusive, Enteral Nutrition in Very Preterm Infants
Role: collaborator
Iron Treatment for Young Children With Non-anemic Iron Deficiency
Role: collaborator
Acceptance of a Partially Hydrolyzed Formula
Role: lead
Early DHA/ARA Supplementation in Growth-restricted Very Preterm Infants: A Randomized Clinical Trial
Role: collaborator
Growing Up Formula Versus Nutritional Supplements: Effect on Catch up Growth, Micronutrient Status, and Solid Foods Intake in Toddlers With Mild or Moderate Malnutrition
Role: collaborator
Feeding Study in VLBW Premature Infants
Role: lead
Effect of Infant Formula With Bovine Lactoferrin and Low Iron Concentration on Infant Health and Immune Function
Role: collaborator
Clinical Effectiveness and Safety of a Novel Oral Rehydration Solution
Role: lead
Growth and Tolerance of a Partially Hydrolyzed Infant Formula
Role: lead
FIT to Grow Old - Functionality of the Immune System and Healthy Aging
Role: collaborator
Impact of Lactoferrin, a Dietary Supplement, vs. Placebo on Respiratory Tract Infections
Role: lead
Evaluation of the Composition of Human Milk and Health Outcomes in Children
Role: lead
Gastrointestinal Tract Microbiome in Healthy Term Infants Receiving Mother'S-own Breast Milk or Cow's Milk-based Infant Formulas
Role: lead
Nutritive Effects of Cow's Milk-Based Formulas Through 18 Months of Age
Role: lead
Neurodevelopment at 5.5 Years of Age in Children Who Received Infant Formula With Enriched Protein Fractions
Role: lead
PUFA Supplementation in Premature Infants
Role: collaborator